Acadia Pharmaceuticals Stock Price History
| ACAD Stock | USD 14.91 0.34 2.33% |
Below is the normalized historical share price chart for ACADIA Pharmaceuticals extending back to May 27, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ACADIA Pharmaceuticals stands at 14.91, as last reported on the 3rd of May, with the highest price reaching 14.91 and the lowest price hitting 14.57 during the day.
If you're considering investing in ACADIA Stock, it is important to understand the factors that can impact its price. ACADIA Pharmaceuticals retains Efficiency (Sharpe Ratio) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. ACADIA Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ACADIA Pharmaceuticals' market risk adjusted performance of (0.32), and Variance of 6.24 to double-check the risk estimate we provide. At present, ACADIA Pharmaceuticals' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 3.1 B, whereas Common Stock is forecasted to decline to 9,455. . At present, ACADIA Pharmaceuticals' Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 20.24, whereas Price Earnings To Growth Ratio is forecasted to decline to (0.03). ACADIA Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of May 2004 | 200 Day MA 16.7507 | 50 Day MA 16.5374 | Beta 0.538 |
Sharpe Ratio = -0.1222
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACAD |
Estimated Market Risk
| 2.54 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ACADIA Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ACADIA Pharmaceuticals by adding ACADIA Pharmaceuticals to a well-diversified portfolio.
Price Book 3.3185 | Enterprise Value Ebitda 17.2498 | Price Sales 2.5372 | Shares Float 114.4 M | Wall Street Target Price 24.4737 |
ACADIA Pharmaceuticals Stock Price History Chart
There are several ways to analyze ACADIA Stock price data. The simplest method is using a basic ACADIA candlestick price chart, which shows ACADIA Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 20, 2025 | 20.29 |
| Lowest Price | April 8, 2025 | 14.1 |
ACADIA Pharmaceuticals May 3, 2025 Stock Price Synopsis
Various analyses of ACADIA Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ACADIA Stock. It can be used to describe the percentage change in the price of ACADIA Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ACADIA Stock.| ACADIA Pharmaceuticals Price Daily Balance Of Power | 1.00 | |
| ACADIA Pharmaceuticals Price Rate Of Daily Change | 1.02 | |
| ACADIA Pharmaceuticals Accumulation Distribution | 39,971 | |
| ACADIA Pharmaceuticals Price Action Indicator | 0.34 |
ACADIA Pharmaceuticals May 3, 2025 Stock Price Analysis
ACADIA Stock Price History Data
The price series of ACADIA Pharmaceuticals for the period between Sun, Feb 2, 2025 and Sat, May 3, 2025 has a statistical range of 6.19 with a coefficient of variation of 11.08. The prices are distributed with arithmetic mean of 17.09. The median price for the last 90 days is 17.19. The company issued dividends on 2010-06-30.| Open | High | Low | Close | Volume | ||
05/02/2025 | 14.60 | 14.91 | 14.57 | 14.91 | 1,752,858 | |
| 05/01/2025 | 14.63 | 14.78 | 14.20 | 14.57 | 1,432,977 | |
04/30/2025 | 14.36 | 14.65 | 14.18 | 14.60 | 1,863,243 | |
04/29/2025 | 14.66 | 14.68 | 14.38 | 14.43 | 1,587,137 | |
04/28/2025 | 14.80 | 15.02 | 14.26 | 14.66 | 1,466,015 | |
04/25/2025 | 14.79 | 14.83 | 14.47 | 14.73 | 957,584 | |
04/24/2025 | 14.60 | 14.85 | 14.44 | 14.83 | 967,917 | |
04/23/2025 | 14.68 | 14.98 | 14.50 | 14.62 | 1,569,604 | |
| 04/22/2025 | 14.60 | 14.81 | 14.08 | 14.35 | 1,772,488 | |
04/21/2025 | 14.58 | 14.74 | 14.17 | 14.38 | 1,420,070 | |
04/17/2025 | 14.47 | 14.75 | 14.39 | 14.73 | 1,208,871 | |
| 04/16/2025 | 14.88 | 14.88 | 14.34 | 14.57 | 1,147,140 | |
04/15/2025 | 14.77 | 15.18 | 14.77 | 14.99 | 1,056,736 | |
04/14/2025 | 14.86 | 15.00 | 14.45 | 14.86 | 1,218,454 | |
| 04/11/2025 | 14.17 | 14.61 | 13.73 | 14.58 | 1,904,307 | |
| 04/10/2025 | 14.57 | 14.76 | 13.54 | 14.11 | 1,913,282 | |
04/09/2025 | 13.78 | 15.19 | 13.40 | 14.96 | 3,496,492 | |
| 04/08/2025 | 14.82 | 15.22 | 13.87 | 14.10 | 2,162,363 | |
04/07/2025 | 14.82 | 15.70 | 14.43 | 14.61 | 2,167,515 | |
| 04/04/2025 | 15.93 | 15.97 | 15.28 | 15.38 | 2,155,317 | |
04/03/2025 | 16.27 | 16.43 | 16.01 | 16.12 | 1,509,189 | |
04/02/2025 | 16.21 | 16.73 | 16.18 | 16.62 | 2,244,937 | |
04/01/2025 | 16.56 | 16.77 | 16.15 | 16.32 | 2,613,006 | |
03/31/2025 | 16.71 | 16.88 | 16.28 | 16.61 | 1,688,695 | |
| 03/28/2025 | 17.16 | 17.22 | 16.92 | 17.07 | 872,276 | |
03/27/2025 | 17.10 | 17.31 | 16.94 | 17.19 | 1,374,613 | |
| 03/26/2025 | 17.05 | 17.09 | 16.86 | 17.03 | 902,668 | |
| 03/25/2025 | 17.21 | 17.39 | 16.95 | 17.11 | 1,005,128 | |
| 03/24/2025 | 17.20 | 17.50 | 17.02 | 17.23 | 1,065,952 | |
03/21/2025 | 17.04 | 17.31 | 16.67 | 16.79 | 4,036,445 | |
03/20/2025 | 17.10 | 17.43 | 17.10 | 17.18 | 1,517,300 | |
03/19/2025 | 17.26 | 17.60 | 17.07 | 17.29 | 1,207,361 | |
03/18/2025 | 16.96 | 17.45 | 16.79 | 17.28 | 1,333,844 | |
03/17/2025 | 17.54 | 17.66 | 17.03 | 17.20 | 1,633,570 | |
03/14/2025 | 16.91 | 17.70 | 16.70 | 17.50 | 1,951,221 | |
03/13/2025 | 16.67 | 16.91 | 16.59 | 16.78 | 1,293,229 | |
03/12/2025 | 17.23 | 17.40 | 16.75 | 16.77 | 1,632,262 | |
03/11/2025 | 17.10 | 17.45 | 16.86 | 17.19 | 1,557,599 | |
03/10/2025 | 17.35 | 17.68 | 17.07 | 17.19 | 1,788,722 | |
| 03/07/2025 | 17.62 | 17.86 | 17.33 | 17.56 | 1,371,928 | |
03/06/2025 | 17.85 | 18.15 | 17.59 | 17.61 | 1,671,339 | |
03/05/2025 | 18.37 | 18.52 | 18.02 | 18.08 | 1,560,674 | |
03/04/2025 | 18.16 | 18.54 | 17.85 | 18.26 | 1,585,712 | |
03/03/2025 | 19.56 | 19.69 | 18.10 | 18.16 | 2,201,553 | |
| 02/28/2025 | 19.04 | 19.62 | 19.00 | 19.60 | 1,524,934 | |
02/27/2025 | 19.44 | 20.62 | 18.83 | 19.34 | 2,926,563 | |
02/26/2025 | 19.08 | 19.65 | 18.93 | 19.00 | 1,292,448 | |
02/25/2025 | 19.52 | 19.72 | 18.90 | 19.01 | 1,744,658 | |
| 02/24/2025 | 19.96 | 19.98 | 19.44 | 19.48 | 1,727,546 | |
| 02/21/2025 | 20.51 | 20.68 | 19.92 | 19.95 | 1,995,038 | |
02/20/2025 | 19.62 | 20.43 | 19.61 | 20.29 | 2,411,678 | |
02/19/2025 | 19.56 | 20.06 | 19.56 | 19.67 | 1,083,394 | |
02/18/2025 | 20.00 | 20.29 | 19.52 | 19.74 | 2,178,359 | |
02/14/2025 | 19.80 | 20.22 | 19.73 | 20.04 | 1,206,167 | |
02/13/2025 | 19.24 | 19.83 | 18.82 | 19.77 | 3,437,738 | |
02/12/2025 | 18.29 | 19.11 | 18.20 | 19.10 | 2,720,579 | |
02/11/2025 | 18.63 | 18.70 | 18.11 | 18.49 | 1,455,379 | |
02/10/2025 | 18.58 | 18.91 | 18.39 | 18.88 | 1,567,296 | |
02/07/2025 | 19.06 | 19.15 | 18.52 | 18.55 | 1,144,066 | |
02/06/2025 | 19.70 | 19.70 | 19.09 | 19.13 | 1,015,627 | |
02/05/2025 | 18.92 | 19.65 | 18.79 | 19.60 | 1,706,886 |
About ACADIA Pharmaceuticals Stock history
ACADIA Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ACADIA is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ACADIA Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ACADIA Pharmaceuticals stock prices may prove useful in developing a viable investing in ACADIA Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 166.4 M | 85.2 M | |
| Net Loss | -194.4 M | -204.1 M |
ACADIA Pharmaceuticals Quarterly Net Working Capital |
|
ACADIA Pharmaceuticals Stock Technical Analysis
ACADIA Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
ACADIA Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ACADIA Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of ACADIA Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ACADIA to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.12) | |||
| Treynor Ratio | (0.33) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |